PPAR𝜹 Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities
Main Authors: | Mylène Perreault, David V. Erbe, James F. Tobin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/125387 |
Similar Items
-
Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
by: David C. D. Hope, et al.
Published: (2021-09-01) -
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
by: Jonathan E. Campbell
Published: (2021-04-01) -
Glucagon and GLP-1 receptor dual agonism : a therapeutic approach for the treatment of obesity
by: Cegla, Jaimini
Published: (2015) -
Obesity alters global response to ischemia and GLP-1 agonism
by: Sassoon, Daniel Jay
Published: (2016) -
Opioid use disorder and treatment: challenges and opportunities
by: Kim A. Hoffman, et al.
Published: (2019-11-01)